Education, Science, Technology, Innovation and Life
Open Access
Sign In

iGFBP-1 Rapid Test Cassette (Vaginal Secretion): Performance Characteristics and Clinical Application in Detecting Rupture of Fetal Membranes

Download as PDF

DOI: 10.23977/medsc.2025.060419 | Downloads: 4 | Views: 128

Author(s)

Zhang Lei 1, Yang Feng 2, Zhu Junzhe 3

Affiliation(s)

1 Zhejiang Gongshang University, Hangzhou, Zhejiang, 310018, China
2 Community Health Service Center, Hangzhou, Zhejiang, 310000, China
3 Wenzhou Medical University, Wenzhou, Zhejiang, 310000, China

Corresponding Author

Zhang Lei

ABSTRACT

The iGFBP-1 Rapid Test Cassette (Vaginal Secretion) is a visually interpreted, qualitative immunochromatographic assay designed for the detection of insulin-like growth factor-binding protein 1 (iGFBP-1) in vaginal secretions of pregnant women. As a major protein marker of amniotic fluid, iGFBP-1 serves as an indicator for the diagnosis of rupture of fetal membranes (ROM). This study aims to do clinical studies of iGFBP-1 Rapid Test Cassette (Vaginal secretion) with the iGFBP-1 positive specimens and negative specimens which confirmed with other Rapid Test. A total of 230 vaginal swab specimens (100 iGFBP-1 positive and 130 iGFBP-1 negative, confirmed by another commercial iGFBP-1 rapid test) were analyzed. The results demonstrated high relative sensitivity (98.0%, 95%CI: 93.0%-99.8%), relative specificity (97.7%, 95%CI: 93.4%-99.5%) and overall accuracy (97.8%, 95%CI: 95.0%-99.3%). Intra-assay and inter-assay precision were excellent, with >99% correct identification of specimens across three lots. No cross-reactivity was observed with common vaginal microorganisms and no interference was detected from substances such as globulin, hemoglobin or bilirubin at clinically relevant concentrations. These findings indicate that the iGFBP-1 Rapid Test Cassette is a reliable, rapid, and practical tool for the qualitative detection of iGFBP-1 in vaginal secretions, aiding in the timely diagnosis of ROM and supporting clinical decision-making in obstetric care.

KEYWORDS

iGFBP-1; Rapid Test Cassette; Vaginal Secretion; Rupture of Fetal Membranes (ROM); Immunochromatographic Assay; Prenatal Diagnosis

CITE THIS PAPER

Zhang Lei, Yang Feng, Zhu Junzhe, iGFBP-1 Rapid Test Cassette (Vaginal Secretion): Performance Characteristics and Clinical Application in Detecting Rupture of Fetal Membranes. MEDS Clinical Medicine (2025) Vol. 6: 128-132. DOI: http://dx.doi.org/10.23977/medsc.2025.060419.

REFERENCES

[1] American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 179: Prelabor rupture of membranes. Obstet Gynecol. 2017;130(4):e197-e211.
[2] Mercer BM, Parry S, Farrell SA, et al. Management of term and preterm prelabor rupture of membranes. Obstet Gynecol Surv. 2018;73(1):31-44.
[3] Committee on Obstetric Practice. Committee Opinion No. 723: Prelabor rupture of membranes. Obstet Gynecol. 2018; 131(4):e142-e153.
[4] Cereda M, Contro E, Romanini C, et al. Accuracy of diagnostic tests for preterm prelabor rupture of membranes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2016;29(17):2801-2811.
[5] Ranheim T, Krogstad T, Skjeldestad FE, et al. Insulin-like growth factor binding protein-1 in cervical and vaginal secretions as a marker for preterm premature rupture of the fetal membranes. Acta Obstet Gynecol Scand. 2001; 80(1): 51-56.
[6] Lee YJ, Kim SH, Park JS, et al. Diagnostic value of insulin-like growth factor binding protein-1 for preterm prelabor rupture of membranes. J Perinat Med. 2015;43(7):787-792.
[7] Kaaja RJ, Jouppila P, Gronroos M, et al. Vaginal IGFBP-1 test in the diagnosis of premature rupture of membranes. Acta Obstet Gynecol Scand. 2000;79(10):874-878.
[8] Chaiworapongsa T, Romero R, Espinoza J, et al. A rapid immunochromatographic test for insulin-like growth factor binding protein-1 in vaginal fluid: a new diagnostic tool for preterm premature rupture of membranes. Am J Obstet Gynecol. 2001;185(5):1167-1173.
[9] Hangzhou AllTest Biotech Co., Ltd. iGFBP-1 Rapid Test Cassette (Vaginal Secretion) Package Insert. REF: FIG-502. Revision Date: 2024-11-26.
[10] World Health Organization. Laboratory biosafety guidance related to COVID-19. 2020. Available at: https://www. who.int/publications/i/item/9789240014314.

Downloads: 9611
Visits: 587926

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.